Literature DB >> 35284315

Socioeconomic and clinical factors affecting the proportion of breast conserving surgery in Chinese women with breast cancer.

Jingjing Liu1,2,3,4,5, Dongdong Zhou1,2,3,4,5, Teng Pan1,2,3,4,5, Lixia Cao1,2,3,4,5, Qianxi Yang1,2,3,4,5, Jin Zhang1,2,3,4,5.   

Abstract

Background: This study investigated the socioeconomic and clinical factors affecting the proportion of breast conserving surgery (BCS) in China, to improve the proportion and success rate of BCS in Chinese breast cancer patients.
Methods: Six hundred and forty breast cancer patients treated with BCS were compared with 700 selected breast cancer patients (controls) treated with modified radical mastectomy (MRM) in Tianjin Medical University Cancer Institute and Hospital from January 2005 to January 2018. Patients' socioeconomic and clinical factors were collected through telephone interviews or face-to-face interviews. A total of 5,660 BCS patients were enrolled to analyze independent factors affecting initial positive margins. Chi-squared test and multiple logistic regressions were used to examine factors associated with BCS. The locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS), and overall survival (OS) were calculated using the Kaplan-Meier method and the survival distribution between BCS and MRM groups was compared by log-rank test.
Results: Breast cancer patients who were younger, lived in urban areas, had medical insurance, and higher levels of education and Personal income were more likely to choose BCS. We also observed that patients of Han nationality were more likely to choose BCS. Univariate analysis showed that the frozen section analysis (FSA) positive margin was significantly correlated with tumor distance from the nipple, preoperative magnetic resonance imaging (MRI) examination, T stage, pathological subtype, and lymphovascular invasion (LVI). Multivariate analysis showed the distance from the nipple, T stage, pathological subtype, and LVI, and no preoperative MRI examination were independent predictors of positive resection margins. Multivariate analysis of the correlation between MRI findings and positive resection margins revealed that tumor size, non-mass enhancement (NME), and malignant enhancement surrounding the tumor were independent predictors of positive resection margins. Conclusions: In China, socioeconomic factors largely influence the choice of surgical procedures for breast cancer patients. A gradual reduction in the influence of socioeconomic factors on the proportion of BCS is recommended. Furthermore, preoperative MRI should be encouraged in patients preparing for BCS. Clinicopathological characteristics and MRI findings are significantly associated with a positive resection margin in breast cancer patients. 2022 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Breast conserving surgery (BCS); magnetic resonance imaging (MRI); margin; socioeconomic status

Year:  2022        PMID: 35284315      PMCID: PMC8899422          DOI: 10.21037/gs-22-25

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  23 in total

1.  Significance of linear extent of breast carcinoma at surgical margin.

Authors:  Farbod Darvishian; Steven I Hajdu; Dwight C DeRisi
Journal:  Ann Surg Oncol       Date:  2003 Jan-Feb       Impact factor: 5.344

Review 2.  Local recurrence in lumpectomy patients after imprint cytology margin evaluation.

Authors:  Elizabeth Weinberg; Charles Cox; Elisabeth Dupont; Laura White; Mark Ebert; Harvey Greenberg; Nils Diaz; Vesna Vercel; Barbara Centeno; Alan Cantor; Santo Nicosia
Journal:  Am J Surg       Date:  2004-10       Impact factor: 2.565

3.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.

Authors:  J A van Dongen; A C Voogd; I S Fentiman; C Legrand; R J Sylvester; D Tong; E van der Schueren; P A Helle; K van Zijl; H Bartelink
Journal:  J Natl Cancer Inst       Date:  2000-07-19       Impact factor: 13.506

4.  Are mastectomy rates really increasing in the United States?

Authors:  Elizabeth B Habermann; Andrea Abbott; Helen M Parsons; Beth A Virnig; Waddah B Al-Refaie; Todd M Tuttle
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

5.  Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance.

Authors:  E Ramsay Camp; Priscilla F McAuliffe; Jeffrey S Gilroy; Christopher G Morris; D Scott Lind; Nancy P Mendenhall; Edward M Copeland
Journal:  J Am Coll Surg       Date:  2005-09-23       Impact factor: 6.113

6.  Breast-conserving surgery in Hong Kong Chinese women.

Authors:  Dacita Suen; Lorraine Chow; Ava Kwong
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

7.  Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.

Authors:  Carson Leong; John Boyages; Upali W Jayasinghe; Michael Bilous; Owen Ung; Boon Chua; Elizabeth Salisbury; Angela Y Wong
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

8.  Preoperative breast MRI can reduce the rate of tumor-positive resection margins and reoperations in patients undergoing breast-conserving surgery.

Authors:  Inge-Marie Obdeijn; Madeleine M A Tilanus-Linthorst; Sandra Spronk; Carolien H M van Deurzen; Cécile de Monye; M G Myriam Hunink; Marian B E Menke
Journal:  AJR Am J Roentgenol       Date:  2013-02       Impact factor: 3.959

9.  Predictors of surgical margin status in breast-conserving surgery within a breast screening program.

Authors:  Emil D Kurniawan; Matthew H Wong; Imogen Windle; Allison Rose; Arlene Mou; Malcolm Buchanan; John P Collins; Julie A Miller; Russell L Gruen; G Bruce Mann
Journal:  Ann Surg Oncol       Date:  2008-07-10       Impact factor: 5.344

Review 10.  Breast cancer in China.

Authors:  Lei Fan; Kathrin Strasser-Weippl; Jun-Jie Li; Jessica St Louis; Dianne M Finkelstein; Ke-Da Yu; Wan-Qing Chen; Zhi-Ming Shao; Paul E Goss
Journal:  Lancet Oncol       Date:  2014-06       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.